Phenotypic Heterogeneity in ORAI-1-Associated Congenital Myopathy

Abstract

Introduction ORAI-1 is a plasma membrane calcium release-activated calcium channel that plays a crucial role in the excitation-contraction of skeletal muscles. Loss-of-function mutations of ORAI-1 cause severe combined immunodeficiency, nonprogressive muscle hypotonia, and anhidrotic ectodermal dysplasia. Autosomal dominant gain-of-function mutation causes Stormorken's syndrome, which includes tubular aggregate myopathy along with bleeding diathesis.

Methods This is a description of a genetically confirmed case of ORAI-1-associated myopathy with clinical, histopathological, and imaging characteristics and a detailed literature review.

Results We report an 18-year-old woman who presented with 2-and-a-half year history of slowly progressive proximal lower limb weakness and ophthalmoparesis. Her serum creatine kinase levels were normal. Magnetic resonance imaging of the muscle showed predominant fatty infiltration of the glutei and quadriceps femoris. Histopathological analysis of muscle biopsy was suggestive of congenital fiber-type disproportion (CFTD). Clinical exome sequencing showed novel homozygous nonsense pathogenic variant NC_000012.12 (NM_032790.3): c.205G > T (p.Glu69Ter) in ORAI-1 gene.

Conclusion This report expands the phenotypic spectrum of ORAI-1-related myopathy to include congenital myopathy—CFTD with ophthalmoparesis, a novel manifestation.

Keywords

ORAI-1 / ophthalmoparesis / congenital myopathy / congenital fiber-type disproportion

References

[1] Maus M, Cuk M, Patel B, et al. Store-operated Ca²+ entry controls induction of lipolysis and the transcriptional reprogramming to lipid metabolism. Cell Metab 2017; 25(03) 698-712

[2] Liou J, Kim ML, Heo WD, et al. STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Curr Biol 2005; 15(13) 1235-1241

[3] Zhang SL, Yeromin AV, Zhang XH, et al. Genome-wide RNAi screen of Ca(2+) influx identifies genes that regulate Ca(2+) release-activated Ca(2+) channel activity. Proc Natl Acad Sci U S A 2006; 103(24) 9357-9362

[4] Lacruz RS, Feske S. Diseases caused by mutations in ORAI1 and STIM1. Ann N Y Acad Sci 2015; 1356(01) 45-79

[5] McCarl CA, Picard C, Khalil S, et al. ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia. J Allergy Clin Immunol 2009; 124 (06) 1311-1318.e7

[6] Mercuri E, Talim B, Moghadaszadeh B, et al. Clinical and imaging findings in six cases of congenital muscular dystrophy with rigid spine syndrome linked to chromosome 1p (RSMD1). Neuromuscul Disord 2002; 12(7-8): 631-638

[7] Stramare R, Beltrame V, Dal Borgo R, et al. MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies. Radiol Med 2010; 115(04) 585-599

[8] Freed D, Aldana R, Weber JA, Edwards JS. The Sentieon Genomics Tools - A fast and accurate solution to variant calling from next-generation sequence data. bioRxiv 2017

[9] McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 2010; 26(16) 2069-2070

[10] Zerbino DR, Achuthan P, Akanni W, et al. Ensembl 2018. Nucleic Acids Res 2018; 46(D1): D754-D761

[11] Richards S, Aziz N, Bale S, et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17(05) 405-424

[12] Cassandrini D, Trovato R, Rubegni A, et al; Italian Network on Congenital Myopathies. Congenital myopathies: clinical phenotypes and new diagnostic tools. Ital J Pediatr 2017; 43(01) 101

[13] Clarke NF. Congenital fiber-type disproportion. Semin Pediatr Neurol 2011; 18(04) 264-271

[14] Clarke NF, Waddell LB, Cooper ST, et al. Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion. Hum Mutat 2010; 31(07) E1544-E1550

[15] Lawlor MW, Dechene ET, Roumm E, Geggel AS, Moghadaszadeh B, Beggs AH. Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion. Hum Mutat 2010; 31(02) 176-183

[16] Partiseti M, Le Deist F, Hivroz C, Fischer A, Korn H, Choquet D. The calcium current activated by T cell receptor and store depletion in human lymphocytes is absent in a primary immunodeficiency. J Biol Chem 1994; 269(51) 32327-32335

[17] Fuchs S, Rensing-Ehl A, Speckmann C, et al. Antiviral and regulatory T cell immunity in a patient with stromal interaction molecule 1 deficiency. J Immunol 2012; 188(03) 1523-1533

[18] Picard C, McCarl CA, Papolos A, et al. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med 2009; 360(19) 1971-1980

[19] Conte E, Imbrici P, Mantuano P, et al. Alteration of STIM1/Orai1-mediated SOCE in skeletal muscle: impact in genetic muscle diseases and beyond. Cells 2021; 10(10) 2722

[20] Noury JB, Böhm J, Peche GA, et al. Tubular aggregate myopathy with features of Stormorken disease due to a new STIM1 mutation. Neuromuscul Disord 2017; 27(01) 78-82

[21] Morin G, Biancalana V, Echaniz-Laguna A, et al. Tubular aggregate myopathy and Stormorken syndrome: mutation spectrum and genotype/phenotype correlation. Hum Mutat 2020; 41(01) 17-37

[22] Maul-Pavicic A, Chiang SC, Rensing-Ehl A, et al. ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis. Proc Natl Acad Sci U S A 2011; 108(08) 3324-3329

[23] Chou J, Badran YR, Yee CSK, et al. A novel mutation in ORAI1 presenting with combined immunodeficiency and residual T-cell function. J Allergy Clin Immunol 2015; 136 (02) 479-482.e1

[24] Lian J, Cuk M, Kahlfuss S, et al. ORAI1 mutations abolishing store-operated Ca²+ entry cause anhidrotic ectodermal dysplasia with immunodeficiency. J Allergy Clin Immunol 2018; 142 (04) 1297-1310.e11

RIGHTS & PERMISSIONS

2024 Global Medical Genetics